» Authors » Frederick J Marshall

Frederick J Marshall

Explore the profile of Frederick J Marshall including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 21
Citations 521
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Brownstein M, Simon N, Long J, Yankey J, Maibach H, Cudkowicz M, et al.
J Clin Med . 2020 Nov; 9(11). PMID: 33207828
SRX246 is a vasopressin (AVP) 1a receptor antagonist that crosses the blood-brain barrier. It reduced impulsive aggression, fear, depression and anxiety in animal models, blocked the actions of intranasal AVP...
2.
Masten M, Williams J, Vermilion J, Adams H, Vierhile A, Collins A, et al.
Neurology . 2020 Apr; 94(23):e2436-e2440. PMID: 32300063
Objective: To develop a disease-specific staging system for CLN3 disease and to test the hypothesis that salient and discrete clinical features of CLN3 disease may be used to define disease...
3.
Adams H, Defendorf S, Vierhile A, Mink J, Marshall F, Augustine E
Clin Trials . 2019 Jun; 16(5):555-560. PMID: 31184505
Background: Travel burden often substantially limits the ability of individuals to participate in clinical trials. Wide geographic dispersion of individuals with rare diseases poses an additional key challenge in the...
4.
Mitchell K, Larson P, Starr P, Okun M, Wharen Jr R, Uitti R, et al.
Parkinsonism Relat Disord . 2018 Sep; 60:126-132. PMID: 30220556
Introduction: Many experts assume bilateral deep brain stimulation (DBS) is necessary to improve axial tremor in essential tremor (ET). In the largest clinical trial of DBS for ET to date...
5.
Augustine E, Beck C, Adams H, Defendorf S, Vierhile A, Timm D, et al.
JIMD Rep . 2018 Jun; 43:117-124. PMID: 29923092
Mycophenolate, an immunosuppressant, is commonly used off-label for autoimmune neurological conditions. In CLN3 disease, a neurodegenerative disorder of childhood, preclinical and clinical data suggest secondary autoimmunity and inflammation throughout the...
6.
Delvaux E, Mastroeni D, Nolz J, Chow N, Sabbagh M, Caselli R, et al.
Neurobiol Aging . 2017 Jul; 58:225-237. PMID: 28716532
The need for a reliable, simple, and inexpensive blood test for Alzheimer's disease (AD) suitable for use in a primary care setting is widely recognized. This has led to a...
7.
Wharen Jr R, Okun M, Guthrie B, Uitti R, Larson P, Foote K, et al.
Parkinsonism Relat Disord . 2017 Apr; 40:18-26. PMID: 28400200
Introduction: This study of thalamic deep brain stimulation (DBS) investigated whether a novel constant-current device improves tremor and activities of daily living (ADL) in patients with essential tremor (ET). Methods:...
8.
Low P, Reich S, Jankovic J, Shults C, Stern M, Novak P, et al.
Lancet Neurol . 2015 May; 14(7):710-9. PMID: 26025783
Background: Multiple system atrophy is a rare, fatal neurodegenerative disorder with symptoms of autonomic failure plus parkinsonism, cerebellar ataxia, or both. We report results of the first prospective natural history...
9.
Adams H, Rose K, Augustine E, Kwon J, deBlieck E, Marshall F, et al.
Mol Genet Metab . 2013 Nov; 111(2):197-202. PMID: 24246680
Background And Objectives: Policies for genetic testing in children (GTIC) focus on medical or psychosocial benefit to the child, discouraging or prohibiting carrier testing, and advising caution regarding pre-symptomatic diagnosis...
10.
Mink J, Augustine E, Adams H, Marshall F, Kwon J
J Child Neurol . 2013 Jul; 28(9):1101-5. PMID: 23838030
The neuronal ceroid lipofuscinoses represent a group of disorders characterized by neurodegeneration and intracellular accumulation of an auto-fluorescent lipopigment (ceroid lipofuscin). Together, they represent the most prevalent class of childhood...